| Status | Study |
| Recruiting |
Study Name: Austrian Registry on the Outcome of Monochorionic Pregnancies Condition: Twin Dichorionic Diamniotic Placenta Twin Monochorionic Monoamniotic Placenta Date: 2017-05-15 |
| Recruiting |
Study Name: Neonatal Outcome for Laser Coagulation in Twin-to-twin-transfusion Syndrome Condition: TTTS Date: 2017-05-03 |
| Enrolling by invitation |
Study Name: Laser Photocoagulation in Twin to Twin Transfusion Syndrome Condition: Twin to Twin Transfusion Syndrome. Date: 2015-07-06 Interventions: Device: S-LPC:Selective Laser Photocoagulation Under anesthesia (epidural, general anesthesia with intub |
| Active, not recruiting |
Study Name: Monochorial-diamniotic Pregnancies Complicated With a Twin-to-twin Syndrome Condition: Twin to Twin Transfusion Syndrome Date: 2015-07-02 |
| Completed |
Study Name: Milking Versus Delayed Cord Clamping in Full Term Neonates Condition: Neonatal Anemia Date: 2015-05-17 Interventions: Procedure: cord milking milkin |
| Recruiting |
Study Name: The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome Condition: Fetofetal Transfusion Date: 2014-09-15 |
| Recruiting |
Study Name: Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome Condition: Twin Twin Transfusion Syndrome Date: 2014-04-16 Interventions: Procedure: Sequential laser photocoagulation of communicating vessels. |
| Active, not recruiting |
Study Name: Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates Condition: Anemia, Neonatal Intracranial Hemorrhages Date: 2014-01-29 Interventions: Biological: Umbilical Cord Blood Infusion |
| Recruiting |
Study Name: Optimized Erythropoietin (EPO) Treatment Condition: Neonatal Anemia Date: 2013-05-30 Interventions: Drug: Epoetin Alpha |
| Recruiting |
Study Name: Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk. Condition: Pregnancy; Fetomaternal Hemorrhage Date: 2012-07-25 Interventions: Biological: Immunoglobulin Anti-RhD KamRho-D (Immunoglobulin Anti-RhD): single dose (300mcg/2mL), via in |